Azura Ophthalmics Company
Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD.
.jpeg)
Technology:
Small Molecules
Industry:
Geroscience
Headquarters:
Tel Aviv, Tel Aviv, Israel
Founded Date:
2014-01-01
Employees Number:
1-10
Investors Number:
4
Total Funding:
36000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-10-22
Last Funding Type:
Series C
Register and Claim Ownership